Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,758 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
E2F1: a promising regulator in ovarian carcinoma.
Zhan L, Zhang Y, Wang W, Song E, Fan Y, Wei B. Zhan L, et al. Among authors: song e. Tumour Biol. 2016 Mar;37(3):2823-31. doi: 10.1007/s13277-015-4770-7. Epub 2016 Jan 9. Tumour Biol. 2016. PMID: 26749284 Review.
Autophagy as an emerging therapy target for ovarian carcinoma.
Zhan L, Zhang Y, Wang W, Song E, Fan Y, Li J, Wei B. Zhan L, et al. Among authors: song e. Oncotarget. 2016 Dec 13;7(50):83476-83487. doi: 10.18632/oncotarget.13080. Oncotarget. 2016. PMID: 27825125 Free PMC article. Review.
TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway.
Song Y, Zhou G, Song E, Zhan L, Wang Q, Song H, Xia J, Cong L. Song Y, et al. Among authors: song h, song e. Evid Based Complement Alternat Med. 2022 Nov 7;2022:6235771. doi: 10.1155/2022/6235771. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Jul 19;2023:9863414. doi: 10.1155/2023/9863414. PMID: 36387361 Free PMC article. Retracted.
Aclarubicin and low-dose Cytosine arabinoside in combination with granulocyte colony-stimulating factor in treating acute myeloid leukemia patients with relapsed or refractory disease and myelodysplastic syndrome: a multicenter study of 112 Chinese patients.
Li JM, Shen Y, Wu DP, Liang H, Jin J, Chen FY, Song YP, Song EY, Qiu XF, Hou M, Qiu ZC, Shen ZX. Li JM, et al. Among authors: song yp, song ey. Int J Hematol. 2005 Jul;82(1):48-54. doi: 10.1532/IJH97.A10424. Int J Hematol. 2005. PMID: 16105759 Clinical Trial.
2,758 results